Suchergebnisse - "Maziarz, Richard T."

PubPharm (291)

1

Don't keep me waiting : estimating the lifetime impact of reduced vein-to-vein time for CAR-T treated patients with LBCL

enthalten in: Blood advances | 2024

von Vadgama, S. | Pasquini, M. | Maziarz, R. | +7

2

Cost-Effectiveness of Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Older Patients With High-Risk Myelodysplastic Syndrome : Analysis of BMT CTN 1102

enthalten in: JCO oncology practice | 2024

von Saber, W. | Bansal, A. | Li, L. | +14

3

The impact of omidubicel on immune reconstitution and infections in cord blood transplant patients

enthalten in: Expert opinion on biological therapy | 2024

von De Sa, H. | Maziarz, R. | Gandhi, A.

4

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT : a BMT-CTN biorepository study

enthalten in: Bone marrow transplantation | 2024

von McCarthy, P. | Attwood, K. | Liu, X. | +18

5

Health care costs among patients with hematologic malignancies receiving allogeneic transplants : a US payer perspective

enthalten in: Blood advances | 2024

von Maziarz, R. | Gergis, U. | Edwards, M. | +8

6

A phase II trial of netupitant/palonosetron for prevention of chemotherapy-induced nausea/vomiting in patients receiving BEAM prior to hematopoietic cell transplantation

enthalten in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners | 2024

von Bubalo, J. | Radke, J. | Bensch, K. | +3

7

Can we truly define 'Fitness' for CAR-T therapy in large B cell lymphoma patients?

enthalten in: Chinese clinical oncology | 2024

von Chen, A. | Maziarz, R.

8

Hospitalization and Healthcare Resource Utilization of Omidubicel-Onlv versus Umbilical Cord Blood Transplantation for Hematologic Malignancies : Secondary Analysis from a Pivotal Phase 3 Clinical Trial

enthalten in: Transplantation and cellular therapy | 2023

von Majhail, N. | Miller, B. | Dean, R. | +4

9

Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD : final report of BMT CTN 2002

enthalten in: Bone marrow transplantation | 2023

von Meyers, G. | Hamadani, M. | Martens, M. | +22

10

Estimating the Lifetime Medical Cost Burden of an Allogeneic Hematopoietic Cell Transplantation Patient

enthalten in: Transplantation and cellular therapy | 2023

von Maziarz, R. | Devine, S. | Garrison, L. | +4

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[30]